Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
- 5 June 2010
- journal article
- research article
- Published by Elsevier BV in Virology
- Vol. 401 (2), 228-235
- https://doi.org/10.1016/j.virol.2010.02.029
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (048053)
- Vaccine Research Center
- National Institutes of Health
This publication has 62 references indexed in Scilit:
- Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in UgandaPLoS Pathogens, 2008
- Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoproteinVirology, 2008
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008
- Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and InfectivityJournal of Virology, 2007
- Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding EventsJournal of Virology, 2007
- Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA VaccinesJournal of Virology, 2007
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in MonkeysPLoS Pathogens, 2007
- Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated EntryJournal of Virology, 2006
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006
- Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus GlycoproteinJournal of Virology, 2006